IS IT RADIOTHERAPY NECESSARY FOR PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBL) PATIENTS ACHIEVING PET NEGATIVITY AFTER IMMUNOCHEMOTHERAPY?